Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Producing Reliable Quantitative Western Blot Data

Published: Monday, June 17, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
The reporting of fold changes in protein expression from western blots is often viewed with skepticism due to questions about the validity of the technique as a quantitative method.

In the May issue of Molecular Biotechnology, researchers at Bio-Rad Laboratories, Inc. reported a method for producing quantitative and reproducible western blot data that could establish the technique’s reputation for reliable quantitation.

Western blotting has been practiced for several decades and is performed routinely in labs to assess the presence of specific target proteins in complex samples. Although the scientific community has historically reported fold changes in protein expression by measuring the differential density of the target protein bands among the samples on western blots, the technique is generally considered to yield only semi- or nonquantitative data because of the methods, reagents, and instruments used to generate these data. This shortcoming led the authors to undertake the present study.

“In my visits to labs, researchers having been asking me how to more rigorously approach western blotting quantitation,” said Dr. Sean Taylor, lead author and a Bio-Rad field applications specialist. “We wrote this article to demonstrate how the application of a simple workflow coupled with the use of updated reagent and instrument technologies can ensure the production of quantifiable results from chemiluminescent western blots.”

Accurate normalization for loading differences is a solvable challenge 
To ensure accuracy in western blotting, loading controls are used to normalize for errors that can result from imprecise protein estimation, pipetting inaccuracy, or uneven protein transfer. The most common loading controls are housekeeping proteins. However, these proteins are generally highly expressed in samples and are frequently overloaded in a gel lane with the much lower abundance target protein, thus reducing their usefulness for normalization.

In these instances, total protein normalization using stain-free technology may be a suitable alternative. The study found that using stain-free imaging to quantify the total amount of proteins in each lane yielded results that closely matched the confirmed amounts, supporting the validity of this normalization method. This result was in direct contrast to quantification using the relative density of GAPDH, a common housekeeping protein, which did not correspond well to the actual amounts due to signal saturation at high sample loads.

Modern imaging technology has a greater dynamic range than film
The study also dispelled the widely held view that film should be the method of choice for detecting chemiluminescent western blots. Using a twofold dilution series of a protein lysate, the researchers reported that the CCD-based imaging system provided a linear dynamic range nearly an order of magnitude greater than film (0.04–2.5 ng vs. 0.04–0.31 ng) for the probed target protein. This permitted accurate quantification of the relative target band density between the gel lanes with the imaging system versus film for the identical blots.

“This paper demonstrates how to validate antibodies using an imaging system to ensure that individual samples are diluted and loaded within the quantitative linear dynamic range of each antibody to produce excellent densitometric data,” Taylor said. “It also shows how stain-free technology is a great alternative to traditional housekeeping proteins for normalization.”

Click below to read the Molecular Biotechnology paper describing how to reliably quantify proteins in your next western blot experiment.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Droplet Digital PCR Enables Measurement of Potential Cancer Survival Biomarker
Study paves the way for further research into the role of TIL quantification in immunotherapy and as a cancer survival predictor.
Tuesday, December 10, 2013
Bio-Rad and Myriad RBM Partner to Develop Immunoassay Kits
Partnership to commercialize multiplex biomarker kits for life science research.
Wednesday, August 01, 2012
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!